MBC issues correction over Ursa
Published: 2013-09-27 07:00:00
Updated: 2013-09-27 07:00:00
The broadcaster MBC on Wednesday issued the correction over Daewoong Pharm’s Ursa, thehe best-selling hepatic function medicine, denying that Ursa is nearly similar to a digestive, not a drug to combat fatigue, which was raised by a civic group on Sept. 7.
In its Wednesday evening news, MBC sa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
